The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 11th 2025
States have expanded access to over-the-counter ivermectin, raising concerns among health experts about safety, misinformation, and self-medication risks.
Treatment for HER2-Negative Breast Cancer with Germline BRCA Mutation Granted FDA Approval
October 16th 2018Talazoparib, a poly ADP-ribose polymerase (PARP) inhibitor, is indicated for patients with known deleterious or suspected deleterious gBRCA-mutated breast cancer who are selected for the therapy based on an FDA-approved companion diagnostic.
Read More
CMS Officials Propose Requiring Drug Manufacturers to Disclose Drug Prices in TV Ads
October 16th 2018Officials with the Pharmaceutical Research and Manufacturing Association (PhRMA) said in a press release that they plan to request member companies’ direct-to-consumer (DTC) television advertisements to direct patients to information about medicine costs, including the list price of the medicine, out-of-pocket costs or other context about the potential cost of the medicine and available financial assistance.
Read More
Female Industry Leaders Weigh in on Pharmacy Ownership for National Women Pharmacists Day
October 12th 2018In recognition of the first National Women Pharmacists Day today, October 12, Specialty Pharmacy Times conducted an interview with female pharmacy leaders and a pharmacy student to hear their unique perspectives on the state of the industry, as well as challenges and opportunities in store ownership.
Read More
October 10 Pharmacy Week in Review: Women Pharmacists Day Celebrated, HPV Vaccine Use Expanded
October 12th 2018This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Watch
Inhalation Spray Label Revised to Include New Data, Broader Indication
October 12th 2018The FDA has approved new labeling for Boehringer Ingelheim's Stiolto Respimat (tiotropium bromide & olodaterol) Inhalation Spray that includes data showing a meaningful reduction in COPD exacerbations driven by tiotropium.
Read More
Pharmacists: Partner with Physicians on Chronic Care to Better Manage Patients
October 8th 2018It is important for pharmacists to position themselves as the health experts that can help patients with chronic conditions, and as the experts on the Medicare payment codes that can benefit both physician and pharmacist.
Read More